Rate My Professor Kathryn Greenwood

Greenwood's research specializations encompass improving social, functional, and physical health outcomes for people with psychosis, examining cognition and self-beliefs, promoting engagement with evidence-based psychological interventions, and enabling service-user-led evaluations. She has acted as Chief Investigator on studies including the EYE-2 pragmatic cluster randomised controlled trial of the Early Youth Engagement intervention in first-episode psychosis services and contributed to the SlowMo randomised controlled trial on psychotherapy for cognitive biases in schizophrenia. Over recent years, she has secured more than £2.2 million in grant income as Chief Investigator and participated as co-applicant on projects worth a further £18 million. Key publications include "A qualitative process evaluation of social recovery therapy for enhancement of social recovery in first-episode psychosis (SUPEREDEN3)" (2022), "Psychotherapy of Biases in Cognition in Schizophrenia: the SlowMo Randomised Controlled Trial for Paranoia, Outcomes and Mechanisms" (2022), "Crisis-focused Cognitive Behavioural Therapy for psychosis (CBTp) in acute mental health inpatient settings (the CRISIS study): protocol for a pilot randomised controlled trial" (2022), and "The Early Youth Engagement (EYE-2) intervention in first-episode psychosis services: pragmatic cluster randomised controlled trial and cost-effectiveness evaluation" (2025). Her body of 142 publications has received over 4,700 citations, demonstrating substantial impact in the field of clinical psychology and psychosis research.